COMMUNIQUÉS West-GlobeNewswire

Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty
13/05/2024
Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty Paris, May 13, 2024 . As the largest private contributor to the security and [...]
Communiqué de presse : Sanofi investit plus d’un milliard d’euros supplémentaires dans la production de médicaments en France, en plus des 2,5 milliards d’euros déjà engagés dans de grands projets de souveraineté sanitaire
13/05/2024
Sanofi investit plus d’un milliard d’euros supplémentaires dans la production de médicaments en France, en plus des 2,5 milliards d’euros déjà engagés dans de grands projets de souveraineté sanitaire Paris, le 13 mai [...]
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
13/05/2024
If approved, Dupixent would be the first treatment in the U.S. indicated for adolescents aged 12-17 years with inadequately controlled CRSwNP, a condition driven in part by underlying type 2 inflammation that obstructs [...]
Introducing PBC BioVet: A New Frontier in Veterinary Healthcare
13/05/2024
SHANNON, Ireland, May 13, 2024 (GLOBE NEWSWIRE) -- PBC Biomed is proud to unveil its latest venture, PBC BioVet, a dedicated affiliate aimed at revolutionizing veterinary healthcare. With a steadfast commitment to [...]
Présentation de PBC BioVet : une nouvelle frontière dans les soins de santé vétérinaires
13/05/2024
SHANNON, Irlande, 13 mai 2024 (GLOBE NEWSWIRE) -- PBC Biomed est fier de dévoiler son tout nouveau projet, PBC BioVet, une filiale entièrement dédiée aux soins vétérinaires. Fermement résolu à influencer [...]
ArcScan's Insight® 100 Ophthalmic Ultrasound Imaging System Approved in China
13/05/2024
First-of-its-Kind Computer-Controlled Robotic Instrument Receives NMPA Certification DENVER, May 13, 2024 (GLOBE NEWSWIRE) -- ArcScan, Inc., a global medical technology company dedicated to helping ophthalmologists [...]
TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award Finalist in the 2024 Citeline Awards
12/05/2024
BOSTON, May 12, 2024 (GLOBE NEWSWIRE) -- The TrialWire™ Rapid Patient Recruitment Platform, the only pay-per-enrolled fixed-fee solution powered by AI and algorithms, has been selected as a finalist by Citeline in three [...]
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
12/05/2024
Company announcement – No. 25 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, May 12 [...]
Le KFSH&RC s’efforce d’être un pionnier dans la valorisation optimale des dépenses de santé
12/05/2024
Le Dr Al Fayyadh à l’Université de Harvard : « Nous nous reposons sur la technologie pour relever les enjeux de santé à l’échelle mondiale » RIYAD, Arabie saoudite, 12 mai 2024 (GLOBE NEWSWIRE) -- Le Dr Majid Al Fayyadh [...]
iTeos fait le point sur ses activités et publie ses résultats financiers pour le premier trimestre 2024
11/05/2024
- Le doublet belrestotug + dostarlimab a dépassé les critères d’efficacité prédéfinis pour une activité cliniquement pertinente constatée lors d’une évaluation intérimaire de Phase 2 sur GALAXIES Lung-201 - Une [...]
Le KFSH&RC repousse les limites et célèbre une année couronnée de succès pour trois de ses centres d’excellence
11/05/2024
RIYAD, Arabie saoudite, 11 mai 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre, ci-après « KFSH&RC », soit l’hôpital spécialisé et centre de recherche King Faisal, célèbre une année [...]
iTeos Therapeutics annonce une offre directe enregistrée de 120 millions de dollars
11/05/2024
- Pilotage assuré par les investisseurs actuels RA Capital Management et Boxer Capital - Prix d’achat fixé à 17,50 dollars, soit une prime d’environ 44 % par rapport à la dernière clôture - Renforcement du bilan avec [...]
KFSH&RC Strives to Pioneer in Maximizing Healthcare Spending Value
11/05/2024
Dr. Al Fayyadh at Harvard: We Leverage Technology to Tackle Global Health Challenges RIYADH, Saudi Arabia, May 11, 2024 (GLOBE NEWSWIRE) -- Dr. Majid Al Fayyadh, CEO of King Faisal Specialist Hospital and Research [...]
Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives
10/05/2024
Supports expansion of Tevogen’s ExacTcell™ platform toward additional clinical trials Bolsters a financial path to positive cashflow and minimizes dilution WARREN, N.J., May 10, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio [...]
Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/05/2024
SAN DIEGO, May 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on May 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock [...]
Evaxion Receives Nasdaq Notification
10/05/2024
COPENHAGEN, Denmark, May 10, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today [...]
Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates
10/05/2024
JERUSALEM, May 10, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins, today reported financial [...]
Atrion Reports First Quarter 2024 Results
10/05/2024
ALLEN, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the first quarter ended March 31, 2024. Revenues for the first quarter of 2024 totaled $47.3 million [...]
Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
10/05/2024
MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and [...]

Pages